After being fired, I became the light of medicine

Chapter 11 New Reward - ITG Human Genitourinary

As the words fell, the picture gradually became blurry.

[Blood Sorrow plot simulation ends]

【Completion degree 100%】

[Ending: A Benevolent Doctor]

[This simulation score: S]

[Reward: 10 energy points]

【Award: "ITG recombinant human myelopoietin" crystal patent and production process. 】

【Award: "ITG recombinant human myelopoietin" pharmacokinetics, toxicokinetics, ethics, acute toxicity, and chronic toxicity data analysis materials. 】

【Award: Complete Phase I and Phase II clinical data of “ITG recombinant human myelopoietin”. 】

ITG recombinant human myelopoietin?
Looking at the long list of rewards, Zhang Yang's eyes fell on the most crucial drug reward.

what is this?
When he opened the instruction manual, he jumped up.

What the hell!

Is this a drug that can regenerate new bone marrow stem cells through recombination, thereby curing "plastic anemia"? !
Completely cured?!
Aplastic anemia!

Zhang Yang's breathing became rapid.

As we all know, the biggest difference between aplastic anemia and leukemia is that aplastic anemia is an autoimmune disease, which is caused by problems with one's own bone marrow stem cells!

Therefore, aplastic anemia is not even like leukemia or cancer, where bad lesions can be removed through chemotherapy, targeted drugs or surgery, and it may even be cured.

Aplastic anemia requires lifelong medication and is almost impossible to cure!

And now...!
hiss! !

Zhang Yang couldn't wait to collect the reward, but as soon as the thought came to his mind, he suddenly thought of the little boy's sister.

"Let's see the ending first!"

Entering the replay, this time Zhang Yang did not return to the void, but automatically entered the God's perspective.

Five minutes later, the speeding ambulance did not drive into the emergency center, but quickly arrived downstairs of the second inpatient department.

Thanks to the advance arrangements made by Director Feng of the Hematology Department, the hematologists were already prepared and the patient was immediately pushed into the sterile ward for isolated rescue.

Three hours later, the patient's consciousness gradually recovered from a blurred state, and the CT results also showed that the amount of cerebral hemorrhage was less than 3ML.

This means that the girl does not need to undergo a craniotomy.

After 24 hours, the patient's vital signs were stable and his life was no longer in danger. At the same time, he officially started treatment for aplastic anemia.

Zhang Yang breathed a sigh of relief, he was finally rescued!

The scene ends here, and a text summary appears before your eyes.

[The treatment of aplastic anemia is the same as most blood diseases, with two options: drug therapy and hematopoietic stem cell transplantation. ]

【Since the cost of transplantation treatment was as high as hundreds of thousands of yuan, the patient finally chose conservative drug treatment. 】【However, aplastic anemia is an immune disease that cannot be completely cured. It not only requires long-term combined treatment with multiple drugs, but the cost of drug treatment is also not low, which makes this already miserable family even worse. 】

[Fortunately, the medical insurance can reimburse part of the cost, and the girl is also very strong; five years later, the boy successfully enrolled in a key university with the support of his sister, and everything began to develop in a good direction. ]

[But...bad luck didn't seem to let these two siblings off.]

[Because of not having a bone marrow transplant, my sister's severe aplastic anemia suddenly relapsed...]

[No miracle this time...]

【The girl is unfortunate, but also lucky. 】

[The mortality rate of severe aplastic anemia is extremely high, and the five-year survival rate is only 10%. Compared with other patients, she is lucky enough.]

"..."

Zhang Yang was silent and stunned.

Although he knew it was just a simulation, he still couldn't suppress the pain and sadness in his heart at this moment.

After a full half hour, he gradually came to his senses, and the "ITG Human Myelopoietin" patent entered his mind with regret.

The complicated and redundant test data were also downloaded to the personal computer.

After exiting the simulator, Zhang Yang lay on the sofa, staring blankly at the ceiling.

This was the first time he truly and deeply understood "aplastic anemia".

After lying down for a while, he sat up again, took out his laptop and began to search for information about "aplastic anemia".

[There are currently nearly 600 million blood disease patients in China, of which about 150 million suffer from "plastic anemia." ]

[After treatment, the condition of some patients has been effectively controlled, and they can live and work normally. Their blood routine indicators are basically normal and their quality of life is good. ]

[However, the vast majority of patients are in serious condition, with frequent infections, bleeding and other symptoms, and need to rely on blood transfusions and drug treatments for a long time to maintain life.]

[These patients have low immunity and weak bodies, and are unable to live and work normally. Women are even unable to have children.]

[Currently, the cost of treating "aplastic anemia" in China is also relatively high. The most basic monthly treatment cost is about 2000-3000 yuan. If imported drugs are taken, the cost is impossible to estimate...]

After reading to the end, Zhang Yang quietly closed his notebook, and the word "ITG human myelopoietin" emerged in his mind.

If "Qingshan Avatrombopag" is the world's top drug for treating blood diseases and can maintain the patient's blood count to the greatest extent, then!

Only "ITG human myelopoietin" can completely change the fate of all "aplastic anemia" patients!

He clenched his fists.

But the next second, he calmed down.

It is definitely not possible to apply for clinical trials in the short term.

If the development of Qingshan Avatrombopag can be explained by accidental discovery, then the development of a drug that can completely cure aplastic anemia just a few weeks later is simply amazing.

By then, everyone will see that there is something wrong with Qingshan Pharmaceutical.

The only solution is to take it slow and wait for Qingshan Avatrombopag to complete its clinical trials!
(End of this chapter)